Bloomberg Intelligence Podcast Highlights: Eli Lilly's Acquisition, ETFs, and US Climate Goals with Clean Hydrogen
Key Ideas
- Eli Lilly's acquisition of Biotech company Morphic discussed by experts in the industry.
- Insights shared on the current state of ETFs by Sean O'Hara, President of Pacer ETFs.
- Investment advice and strategies provided by Jared Dillian, Founder of The Daily Dirtnap.
- Martin Tengler, Head of Hydrogen at Bloomberg BNEF, discusses US climate goals utilizing clean hydrogen.
In this Bloomberg Intelligence podcast, various experts from different industries shared their insights on significant developments. Sam Fazeli, Bloomberg Intelligence's Director of Research for Global Industries and Senior Pharmaceuticals, discussed Eli Lilly's agreement to acquire Biotech company Morphic, shedding light on the implications of this move in the pharmaceutical sector. Investment Analyst Shelby McFaddin from Motley Fool Asset Management provided valuable perspectives on investment strategies. Sean O'Hara, President of Pacer ETFs, discussed the current landscape of ETFs, offering valuable information for investors. Jared Dillian, an author and Founder of The Daily Dirtnap, shared his expert advice on what investors should focus on in the current market. Additionally, Martin Tengler, Bloomberg BNEF's Head of Hydrogen, highlighted the role of clean hydrogen in achieving US climate goals, emphasizing its importance in the transition towards sustainable energy sources. The podcast covered a wide range of topics, providing valuable insights for professionals and enthusiasts across various sectors.